1-18 of 18
blast cells
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Mechanisms of and approaches to overcoming resistance to immunotherapy

Liora Schultz, Rebecca Gardner
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2019) 2019 (1): 226–232.
https://doi.org/10.1182/hematology.2019000018
Published: 2019
Journal Articles

Scherber RM, Mesa RA. Managing myelofibrosis (MF) that “blasts” through: advancements in the treatment of relapsed/refractory and blast-phase MF. Hematology Am Soc Hematol Educ Program . 2018;2018:118-126.

Journal: Hematology
Hematology Am Soc Hematol Educ Program (2019) 2019 (1): 630.
https://doi.org/10.1182/hematology.201900100
Published: 2019
Journal Articles

Idiopathic aplastic anemia vs hypocellular myelodysplastic syndrome

Jibran Durrani, Jaroslaw P. Maciejewski
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2019) 2019 (1): 97–104.
https://doi.org/10.1182/hematology.2019000019
Published: 2019
Journal Articles

Antibody-based therapies in patients with acute lymphoblastic leukemia

Shira Dinner, Michaela Liedtke
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2018) 2018 (1): 9–15.
https://doi.org/10.1182/asheducation-2018.1.9
Published: 2018
Journal Articles

Managing myelofibrosis (MF) that “blasts” through: advancements in the treatment of relapsed/refractory and blast-phase MF

Robyn M. Scherber, Ruben A. Mesa
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2018) 2018 (1): 118–126.
https://doi.org/10.1182/asheducation-2018.1.118
Published: 2018
Journal Articles

MRD in AML: does it already guide therapy decision-making?

Gert Ossenkoppele, Gerrit Jan Schuurhuis
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2016) 2016 (1): 356–365.
https://doi.org/10.1182/asheducation-2016.1.356
Published: 2016
Journal Articles

Evidence for Janus kinase (JAK) inhibitors for the prevention of major morbid events in patients with myeloproliferative neoplasms (MPNs)

Naveen Pemmaraju, Ruben Mesa
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2015) 2015 (1): 649–651.
https://doi.org/10.1182/asheducation-2015.1.649
Published: 2015
Journal Articles

Do somatic mutations in de novo MDS predict for response to treatment?

Mark A. Schroeder, Amy E. DeZern
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2015) 2015 (1): 317–328.
https://doi.org/10.1182/asheducation-2015.1.317
Published: 2015
Journal Articles

Minimal residual disease in acute myeloid leukemia: coming of age

Elisabeth Paietta
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2012) 2012 (1): 35–42.
https://doi.org/10.1182/asheducation.V2012.1.35.3797926
Published: 2012
Journal Articles

Malignant or benign leukocytosis

Tracy I. George
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2012) 2012 (1): 475–484.
https://doi.org/10.1182/asheducation.V2012.1.475.3798515
Published: 2012
Journal Articles

Novel Antibody-Based Therapies For Acute Lymphoblastic Leukemia

Dieter Hoelzer
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2011) 2011 (1): 243–249.
https://doi.org/10.1182/asheducation-2011.1.243
Published: 2011
Journal Articles

High Cytogenetic or Molecular Genetic Risk Acute Myeloid Leukemia

Elihu Estey
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2010) 2010 (1): 474–480.
https://doi.org/10.1182/asheducation-2010.1.474
Published: 2010
Journal Articles

Prognosis of Myelodysplastic Syndromes

Guillermo Garcia-Manero
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2010) 2010 (1): 330–337.
https://doi.org/10.1182/asheducation-2010.1.330
Published: 2010
Journal Articles

Evidence-Based Mini-Review: Should Patients Over the Age of 60 with INT-2 or High-Risk Myelodysplastic Syndrome Undergo Allogeneic Stem Cell Transplantation Prior to Progression to Acute Myelogenous Leukemia?

Mark A. Schroeder, William Blum
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2010) 2010 (1): 322–324.
https://doi.org/10.1182/asheducation-2010.1.322
Published: 2010
Journal Articles

The Biology of Acute Promyelocytic Leukemia and Its Impact on Diagnosis and Treatment

Francesco Lo-Coco, Emanuele Ammatuna
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2006) 2006 (1): 156–161.
https://doi.org/10.1182/asheducation-2006.1.156
Published: 2006
Journal Articles

Treatment of the 5q– Syndrome

Pierre Fenaux, Charikleia Kelaidi
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2006) 2006 (1): 192–198.
https://doi.org/10.1182/asheducation-2006.1.192
Published: 2006
Journal Articles

New Developments in the Therapy of Acute Myelocytic Leukemia

Norbert C. Gorin, Elihu Estey, Richard J. Jones, Hyam I. Levitsky, Ivan Borrello, Shimon Slavin
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2000) 2000 (1): 69–89.
https://doi.org/10.1182/asheducation.V2000.1.69.69
Published: 2000
Journal Articles

Morphology Glossary

James R. McArthur, M.D.
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2000) 2000 (1): 457–474.
https://doi.org/10.1182/asheducation.V2000.1.457.457
Published: 2000